Full-Time

Machine Learning Research Scientist

Generative AI

Achira

Achira

11-50 employees

Atomistic drug-discovery simulation platform

Compensation Overview

$164.6k - $259k/yr

San Francisco, CA, USA + 1 more

More locations: New York, NY, USA

Hybrid

Hybrid roles require time in the office; travel to San Francisco is expected for New York-based hires, and travel is part of all roles.

Category
AI & Machine Learning (1)
Required Skills
LLM
Python
Neural Networks
PyTorch
Machine Learning
Reinforcement Learning

Get referred to Achira

See people who can refer or advise you

Requirements
  • Professional post-degree experience as a machine learning researcher in an industry setting.
  • Demonstrated research impact through conference talks or publications in machine learning venues, open-source contributions, or released models.
  • Proficiency in Python and modern machine learning frameworks, including PyTorch and JAX.
  • Experience collaborating on research projects across multi-person teams.
  • Strong interdisciplinary communication and presentation skills, including the ability to translate ideas to colleagues from non-machine-learning backgrounds.
  • Interest in building generative models that describe real matter.
  • Willingness to pursue frontier problems in physical AI and develop new approaches.
Responsibilities
  • Invent advanced sampling and simulation methods integrating probabilistic inference, deep learning, and reinforcement learning for efficient exploration and simulation of learned energy landscapes for molecular systems.
  • Design and train frontier generative models using diffusion, autoregressive, flow-based, and latent-variable architectures.
  • Build models that map between data distributions to bridge the gap between simulation and reality.
  • Prototype, benchmark, and iterate research ideas into reusable and scalable components across Achira’s ecosystem.
  • Collaborate with physicists and chemists to ensure models are grounded in real physics.
  • Work with research engineers and the infrastructure team to identify support needed to deliver effective research results.
Desired Qualifications
  • Experience working with models that operate on 3-D point clouds and dynamic data.
  • Experience in sequential Monte Carlo methods.
  • Experience with probabilistic programming.
  • Experience with pre-training, mid-training, and post-training parts of the model development process, especially reinforcement learning.
  • Familiarity with statistical mechanics, including sampling, estimators, and the Crooks/Jarzynski perspective of nonequilibrium statistical mechanics.
  • Prior experience working in or with researchers in computational chemistry, biology, or materials science.
  • Experience working with multi-cloud distributed compute systems.
  • Experience working with a multi-site distributed company team.

Achira develops atomistic foundation simulation models for drug discovery, combining geometric deep learning, physics, quantum chemistry, and statistical mechanics to create advanced potentials and generative models. These models produce large synthetic datasets free from experimental artifacts, enabling true inverse design where researchers optimize compounds from desired properties. Achira serves pharmaceutical and biotech clients through partnerships, licensing, and collaborations, differentiating itself by integrating physics-based simulations with data-driven learning to mitigate data scarcity and high costs. The company's goal is to accelerate and make drug discovery more reliable by enabling inverse design that reduces time and expenses in identifying promising compounds.

Company Size

11-50

Company Stage

Seed

Total Funding

$33M

Headquarters

New York City, New York

Founded

2024

Get referred to Achira

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Achira announced a $33M raise from Dimension, NVIDIA, Amplify, and Compound.
  • June 2026 BIO collaboration with NVIDIA expands distribution into life-sciences discovery workflows.
  • Hiring across ML, backend, and distributed systems shows active platform buildout in San Francisco and New York.

What critics are saying

  • Achira is still a 2024 company; product-market fit remains unproven by 2026.
  • Six open roles signal heavy burn before meaningful customer revenue arrives.
  • If NVIDIA or pharma partnerships stall, Achira becomes a research project, not a business.

What makes Achira unique

  • Achira pairs atomistic foundation models with physics, quantum chemistry, and geometric deep learning.
  • Its models generate synthetic molecular data, reducing dependence on scarce, artifact-prone experiments.
  • NVIDIA collaboration on molecular world models gives Achira compute and credibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Hybrid Work Options

Flexible Work Hours

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

PTO/vacation

Paid Vacation

Paid Holidays

Unlimited Paid Time Off

401(k) Retirement Plan

Stock Options

Company Equity

Wellness Program

Mental Health Support

Gym Membership

Conference Attendance Budget

Professional Development Budget

Phone/Internet Stipend

Home Office Stipend

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Confluence

Growth & Insights and Company News

Headcount

6 month growth

20%

1 year growth

20%

2 year growth

28%
The National Herald
Apr 10th, 2025
Achira AI Secures $33M in Funding

Greek startup Achira AI has secured $33 million in funding from top investors, including Dimension, Nvidia, Amplify, and Compound. Achira aims to revolutionize AI-enabled drug development by integrating geometric deep learning, physics, quantum chemistry, and statistical mechanics to create advanced simulation models. This approach seeks to overcome limitations in current biomolecular simulations and machine learning models, accelerating the discovery of new molecules and treatments.

Endpoints News
Feb 21st, 2025
Nvidia-backed Achira debuts, blending AI and physics to model molecules

As he was testing new antivirals to halt a future pandemic, John Chodera encountered an unlikely set of new problems that ultimately helped lead to his new job. The computational ...